Suguru Kadomoto

14PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 30, 2025
Dynamic Changes in Albumin and Systemic Immune-Inflammation Index as Prognostic Markers in Patients Treated with Cabozantinib After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.

Rikushi Fujimura, Hiroshi Yaegashi, Ryunosuke Nakagawa

|Jul 23, 2025
Androgen Receptor-Controlled microRNA-124-3p.2 Suppresses Prostate Cancer Progression via CCL2 Inhibition.

Shuhei Aoyama, Kouji Izumi, Kaoru Hiratsuka

|Jan 18, 2025
Comparison of the efficacy of enfortumab vedotin and paclitaxel plus carboplatin in patients with metastatic urothelial carcinoma.

Ryunosuke Nakagawa, Kouji Izumi, Ren Toriumi

|Jun 28, 2023
Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma.

Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto

|Feb 25, 2023
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma.

Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto

|Dec 08, 2022
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.

Hiroshi Kano, Kouji Izumi, Kaoru Hiratsuka

Pageof 3

Frequent Collaborators

12 joint publications

Kouji Izumi

10 joint publications

Hiroaki Iwamoto

9 joint publications

Atsushi Mizokami

8 joint publications

Tomoyuki Makino